Metsera Inc. (MTSR), a New York-based biotech that went public on Jan. 31 with some fanfare, has a full portfolio of weight-loss drugs in development, using both the hormones already used in existing ...
Fear of nuclear fallout has led to a novel therapeutic approach that could significantly extend the lives of individuals with ...
Daily Wrap on MSN21h
mRNA vaccine shows promise against deadly pancreatic cancerClinical studies suggest that the mRNA vaccine could aid in treating pancreatic cancer, one of the most lethal forms of ...
AMLX has had major setbacks in its lifecycle, including the voluntary withdrawal of an approved drug. Click here to find out ...
The ultimate goal is to develop the facility wherein Hawaii cancer patients will no longer need to travel out of state for ...
Glucagon-like peptite-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With ...
While main results from a platform study of four experimental drugs for amyotrophic lateral sclerosis are negative, it shows ...
Early-phase clinical trials, including phase 1 and some phase 2a studies, serve as a pivotal step for biotech companies, laying the foundation for a drug candidate’s journey to market.
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers at Mayo Clinic are exploring the use of a new drug called ...
COURTESY UH CANCER CENTER The Queen’s Health Systems and University of Hawaii Cancer Center will develop an oncology clinic at the UH John A. Burns School of Medicine in Kakaako. 1 /3 COURTESY UH ...
Objective This study aimed to investigate the incidence of overweight in patients with major depressive disorder (MDD) ...
Learn more about whether Alnylam Pharmaceuticals, Inc. or Vertex Pharmaceuticals Incorporated is a better investment based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results